Deal by Cystic Fibrosis Foundation Raises Cash and Some Concern - NYTimes.com: "Proponents say it speeds drug development while also providing potential monetary rewards that can pay for even more research.
Continue reading the main story
But there is some concern that a profit motive could divert the organizations from their primary mission — helping patients — and create a conflict of interest. For instance, the price of the main drug developed through Cystic Fibrosis Foundation’s investment is $300,000 a year."
'via Blog this'
No comments:
Post a Comment